SCHEMBL15364221

SCHEMBL15364221

Fc1cc(Cl)ccc1-c1nc(-c2ccco2)ns1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.43
PTGS2 P35354 1/20 0.43
PIK3CA P42336 5/20 0.42
PIK3R1 P27986 4/20 0.42
CASP3 P42574 1/20 0.40
MAPT P10636 4/20 0.38
ADORA3 P0DMS8 3/20 0.38
ADORA2A P29274 3/20 0.38
KMT2A Q03164 3/20 0.38
ADORA1 P30542 2/20 0.38
PIK3CD O00329 2/20 0.38
PIK3CB P42338 2/20 0.38
PIK3CG P48736 2/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
GMNN O75496 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4255751 0.90 ALOX15 (0.43) ALOX15PTGS2PIK3CAPIK3R1CASP3
SCHEMBL15364410 0.87 ALOX15 (0.54) ALOX15PTGS2PIK3CAPIK3R1CASP3
SCHEMBL15364034 0.85 ALOX15 (0.43) ALOX15PTGS2PIK3CAPIK3R1CASP3
SCHEMBL3263006 0.85 ALOX15 (0.43) ALOX15PTGS2PIK3CAPIK3R1CASP3
SCHEMBL3261757 0.79 ALOX15 (0.54) ALOX15PTGS2PIK3CAPIK3R1CASP3
SCHEMBL3263388 0.79 PIK3R1 (0.49) ALOX15PIK3CAPIK3R1MAPTADORA3
SCHEMBL15364087 0.78 CASP3 (0.52) ALOX15PIK3CAPIK3R1CASP3MAPT
SCHEMBL3250295 0.77 NPC1 (0.40) ALOX15PTGS2CASP3MAPTADORA2A
SCHEMBL3262950 0.77 ALOX15 (0.43) ALOX15PTGS2PIK3CAPIK3R1CASP3
SCHEMBL13930942 0.75 CASP3 (0.63) ALOX15PTGS2PIK3CAPIK3R1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130296166-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES DIVERGENCE, INC. 2013-11-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130296166-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES ATL3, NOP2, PTMS ALOX15 589/4885PTGS2 1425/4885PIK3CA 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.